138 related articles for article (PubMed ID: 32739410)
1. Hyperammonemic Encephalopathy Exacerbated by Parenteral Nutrition in Fibrolamellar Hepatocellular Carcinoma.
Shah PA; Cho J; Albitar HAH; Pajot G; Liu M; Ravi K
Am J Med; 2020 Dec; 133(12):e745-e746. PubMed ID: 32739410
[No Abstract] [Full Text] [Related]
2. Surgical Debulking for Refractory Hyperammonemic Encephalopathy in Fibrolamellar Hepatocellular Carcinoma.
Solipuram V; Baretti M; Kim AY; Chen LX; Fahrner JA; Gunay-Aygun M; Peng XP; Hardenbergh D; Ferguson A; Griffith P; Wang Y; Brancati M; Gopalakrishna H; Kato T; Shubert C; Laheru D; Yarchoan M
Hepatology; 2021 Nov; 74(5):2899-2901. PubMed ID: 34105830
[No Abstract] [Full Text] [Related]
3. A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation.
Surjan RC; Dos Santos ES; Basseres T; Makdissi FF; Machado MA
Am J Case Rep; 2017 Mar; 18():234-241. PubMed ID: 28270654
[TBL] [Abstract][Full Text] [Related]
4. Hyperammonemic encephalopathy: a rare presentation of fibrolamellar hepatocellular carcinoma.
Sethi S; Tageja N; Singh J; Arabi H; Dave M; Badheka A; Revankar S
Am J Med Sci; 2009 Dec; 338(6):522-4. PubMed ID: 20010160
[TBL] [Abstract][Full Text] [Related]
5. Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers.
Lee JS; Jin HY; Ko JM; Kim SH; Han N; Park BK; Park M; Park HJ; Lee JA
Cancer Res Treat; 2021 Jan; 53(1):283-288. PubMed ID: 32898940
[TBL] [Abstract][Full Text] [Related]
6. Changes in the Body Composition and Nutritional Status after Long-term Rifaximin Therapy for Hyperammonemia in Japanese Patients with Hepatic Encephalopathy.
Ishikawa T; Endo S; Imai M; Azumi M; Nozawa Y; Sano T; Iwanaga A; Honma T; Yoshida T
Intern Med; 2020; 59(20):2465-2469. PubMed ID: 33055469
[TBL] [Abstract][Full Text] [Related]
7. Refractory Hyperammonemic encephalopathy in Fibrolamellar hepatocellular carcinoma, a case report and literature review.
Ahmed A; Ata F; Gaber M; Petkar M; Mahfouz A; Schirmacher P; Musa S; Hashim A
Curr Probl Cancer; 2022 Jun; 46(3):100847. PubMed ID: 35276469
[TBL] [Abstract][Full Text] [Related]
8. Hyperammonemia after chemotherapy in an adolescent with hepatocellular carcinoma.
Winter SS; Rose E; Katz R
J Pediatr Gastroenterol Nutr; 1997 Nov; 25(5):537-40. PubMed ID: 9360210
[No Abstract] [Full Text] [Related]
9. Psychiatric Manifestations of Hyperammonemic Encephalopathy Following Roux-en-Y Gastric Bypass.
Borreggine KL; Hosker DK; Rummans TA; Manning DM
Psychosomatics; 2018; 59(1):90-94. PubMed ID: 28844450
[No Abstract] [Full Text] [Related]
10. Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm.
Chapuy CI; Sahai I; Sharma R; Zhu AX; Kozyreva ON
Oncologist; 2016 Apr; 21(4):514-20. PubMed ID: 26975868
[TBL] [Abstract][Full Text] [Related]
11. [Hyperammonemic encephalopathy and fibrolamellar hepatocellular carcinoma].
Berger C; Dimant P; Hermida L; Paulin F; Pereyra M; Tejo M
Medicina (B Aires); 2012; 72(5):425-7. PubMed ID: 23089120
[TBL] [Abstract][Full Text] [Related]
12. Essential amino acid-induced adult hyperammonemic encephalopathy and hypophosphatemia.
Lamiell JJ; Ducey JP; Freese-Kepczyk BJ; Musio F; Hansberry KL
Crit Care Med; 1990 Apr; 18(4):451-2. PubMed ID: 2108005
[No Abstract] [Full Text] [Related]
13. Reversing Hyperammonemia in Neuroendocrine Tumors.
Broadbridge V; Townsend A; Pittman K; Kimber R; Patterson W; Sukumaran S; Price TJ
J Clin Gastroenterol; 2010 Sep; 44(8):e186-9. PubMed ID: 20453660
[TBL] [Abstract][Full Text] [Related]
14. Acute Onset Hyperammonemic Encephalopathy Related to Fibrolamellar Carcinoma: Another One Bites the Dust.
Surjan RCT; Silveira SP; Pinheiro JLS; Pinheiro PHS; Barros MFA; Soares SRP
Am J Med Sci; 2020 Apr; 359(4):242-244. PubMed ID: 32014302
[No Abstract] [Full Text] [Related]
15. Postchemotherapy hyperammonemic encephalopathy emulating ornithine transcarbamoylase (OTC) deficiency.
Chan JS; Harding CO; Blanke CD
South Med J; 2008 May; 101(5):543-5. PubMed ID: 18414167
[TBL] [Abstract][Full Text] [Related]
16. A Confusing Picture: Refractory Encephalopathy Complicating Nonalcoholic Steatohepatitis.
Kravetz JD; Varma P; Hosseini R; Thomas A; Eder MD
Am J Med; 2020 Oct; 133(10):e546-e548. PubMed ID: 32087105
[No Abstract] [Full Text] [Related]
17. A Randomized Controlled Trial Comparing the Efficacy of a Combination of Rifaximin and Lactulose with Lactulose only in the Treatment of Overt Hepatic Encephalopathy.
Hasan S; Datta S; Bhattacherjee S; Banik S; Saha S; Bandyopadhyay D
J Assoc Physicians India; 2018 Jan; 66(1):32-6. PubMed ID: 30341842
[TBL] [Abstract][Full Text] [Related]
18. Hyperammonemic encephalopathy due to essential amino acid hyperalimentation.
Grazer RE; Sutton JM; Friedstrom S; McBarron FD
Arch Intern Med; 1984 Nov; 144(11):2278-9. PubMed ID: 6437358
[TBL] [Abstract][Full Text] [Related]
19. Acute hyperammonemic encephalopathy in a non-cirrhotic patient with hepatocellular carcinoma reversed by arginine therapy.
Shinde SS; Sharma P; Davis MP
J Pain Symptom Manage; 2014 Apr; 47(4):e5-7. PubMed ID: 24731681
[No Abstract] [Full Text] [Related]
20. Hyperammonemic encephalopathy due to essential amino acid hyperalimentation.
Lee JC; Lai HS; Huang SM; Chang CJ; Wang ST; Chen WJ
J Formos Med Assoc; 1994 Jun; 93(6):486-91. PubMed ID: 7858437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
